Abstract: Aspects of the present disclosure involve an innovative method for detecting error zones from a plurality of volume groups. The method may include creating a plurality of probe groups for error detection; detecting a new error associated with the plurality of probe groups and the plurality of volume groups; retrieving error information associated with the new error, wherein the error information comprises an error source, an error type, and an error time; retrieving an error correlation rule associated with the error information; determining if the error correlation rule is satisfied by the error information and information of other known errors; and identifying a common zone based on the error information and the information of the other known errors as an error zone.

Abstract: Aspects of the present disclosure involve an innovative method for detecting error zones from a plurality of volume groups. The method may include creating a plurality of probe groups for error detection; detecting a new error associated with the plurality of probe groups and the plurality of volume groups; retrieving error information associated with the new error, wherein the error information comprises an error source, an error type, and an error time; retrieving an error correlation rule associated with the error information; determining if the error correlation rule is satisfied by the error information and information of other known errors; and identifying a common zone based on the error information and the information of the other known errors as an error zone.

Abstract: The present invention provides a therapeutic and/or prophylactic agent for inflammatory bowel disease and an NF-kB activation inhibitor, each of which comprises chitin nanofibers or chitosan nanofibers.